Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

American Nobel chemistry laureate Irwin Rose dies at 88

Published 06/03/2015, 01:58 AM
American Nobel chemistry laureate Irwin Rose dies at 88

(Reuters) - American Nobel laureate Irwin Rose, a biochemist whose groundbreaking work helped in the development of treatments for cervical cancer and cystic fibrosis, died on Tuesday, the University of California, Irvine said. He was 88.

Rose won the 2004 Nobel Prize in chemistry, along with Israel Institute of Technology researchers Aaron Ciechanover and Avram Hershko, for research into how cells break down and dispose of old and damaged proteins in plants and animals.

"These findings of the 'kiss-of-death' mechanisms inside cells proved revolutionary, transforming the field of cell biology and ultimately fostering a new understanding of the molecular activity present in cancer and other diseases," the university said.

Errors in the degradation process can lead to diseases such as cervical cancer and cystic fibrosis, the Royal Swedish Academy of Sciences said at the time it made the Nobel award.

Rose died in his sleep in Deerfield, Massachusetts, his family told the university, where he worked during the latter part of his career.

Born in Brooklyn, New York, in 1926, Rose earned a doctoral degree at the University of Chicago in 1952. He spent most of his career at the Fox Chase Center in Philadelphia.

In 1997, Rose took up a special research position with the department of physiology and biophysics at the University of California, Irvine.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.